![L. Arthur Hewitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
L. Arthur Hewitt
Plus aucun poste en cours
Profil
L.
Arthur Hewitt is Chief Development Officer at Adaptin Bio, Inc. since 2025.
Former positions include Director-Scientific Affairs at Shearwater Corp.
from 2002 to 2003, Director-Scientific Affairs at Amgen Canada, Inc. in 2000, Vice President-Drug Development at Ivory Capital Corp.
in 2005, and Chief Scientific Officer & Vice President at Chelsea Therapeutics International Ltd. from 2011 to 2014.
Education includes a doctorate from the University of Montréal.
Postes actifs de L. Arthur Hewitt
| Sociétés | Poste | Début |
|---|
Anciens postes connus de L. Arthur Hewitt
| Sociétés | Poste | Fin |
|---|---|---|
| CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Directeur Technique/Scientifique/R&D | 23/06/2014 |
Ivory Capital Corp.
 Ivory Capital Corp. Financial ConglomeratesFinance Development stage company | Corporate Officer/Principal | 02/08/2005 |
Shearwater Corp.
 Shearwater Corp. Pharmaceuticals: MajorHealth Technology Provides research services focused on health care applications of advanced PEGylation | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Amgen Canada, Inc.
 Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Directeur Technique/Scientifique/R&D | 10/01/2000 |
Formation de L. Arthur Hewitt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Ivory Capital Corp.
Ivory Capital Corp. Financial ConglomeratesFinance Development stage company | Finance |
Chelsea Therapeutics International Ltd.
 Chelsea Therapeutics International Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company developing and commercializing therapeutics for a variety of human diseases | Health Technology |
Shearwater Corp.
Shearwater Corp. Pharmaceuticals: MajorHealth Technology Provides research services focused on health care applications of advanced PEGylation | Health Technology |
University of Montréal
 University of Montréal Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amgen Canada, Inc.
Amgen Canada, Inc. BiotechnologyHealth Technology Operates as human therapeutics company, which develops novel products based on advances in recombinant DNA and molecular biology | Health Technology |
